Abstract
Basal morning humoral (H)-endorphin blood levels were assessed in ten autistic patients, 12 chronic schizophrenic patients and 11 healthy control subjects. Four autistic patients and four schizophrenic patients were drug free for at least 6 months while all other psychiatric patients were under treatment with antidopaminergic agents. Significantly reduced opioid levels were observed in the autistic group (827±103 vs 1121±75 pg-eq/ml, P<0.025), although the difference was actually only 26% of the control mean. A similar tendency toward low H-endorphin levels was also observed in the schizophrenic patients; however this difference was not significant (919±129 vs 1121±75 pg-eq/ml; NS). No significant difference was obtained between subjects suffering from the two psychiatric disorders (827±103 vs 919±129 pg-eq/ml; NS). Various interpretations of the decreased secretion of H-endorphin are discussed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
American Psychiatric Association (1980) Diagnostic and statistical manual of mental disorders, 3rd ed. Washington, D.C.
Berger PA, Watson SJ, Akil H, Elliott GR, Rubin RT, Pfefferbaum A, Davis KL, Barchas JD, Li CH (1980) β-endorphin and schizophrenia. Arch Gen Psychiatry 37:635–640
Berger PA, Watson SJ, Akil H, Barchas JD (1981) The effects of naloxone in chronic schizophrenia. Am J Psychiatry 138:913–918
Costa E (1979) Involvement of endorphins in the action of antipsychotic drugs. In: Bunney WE Jr (moderator): Basic and clinical studies of endorphins. Ann Int Med 91:239–250
Domschke W, Dickschas A, Mitznegg P (1979) CSF β-endorphin in schizophrenia. Lancet 2:1024
Emrich HM, Hollt V, Bergmann M (1980) Plasma levels of beta-endorphin under chronic neuroleptic treatment in schizophrenic patients: failure of naloxone to counteract curative effects of neuroleptic drugs. In: Costa E, Trabuchi M (eds) Neural peptides and neuronal communication. Raven Press, New York, pp 489–502
Jorgensson A, Fog R, Veilis B (1979) Synthetic enkephalin analogue in treatment of schizophrenia. Lancet 1:935
Kalat JW (1978) Letter to the Editor: Speculations on similarities between autism and opiate addiction. J Autism and Child Schizophr 8:477–479
Kanner L (1943) Autistic disturbances of affective contact. Nerv Child 2:217–250
Kline NS, Lehmann HE (1979) Therapy with β-endorphin in psychiatric patients. In: Usdin E, Bunney WE Jr, Kline NS (eds) Endorphin in mental health research. Macmillan Press, London, pp 500–517
Lehman H, Vasavan Nair NP, Kline NS (1979) β-endorphin and nalaxone in psychiatric patients: clinical and biological effects. Am J Psychiatry 136:762–766
Lindstrom LH, Widerlov E, Grunne LM, Wahlstrom A, Terenius L (1978) Endorphins in human cerebrospinal fluid: clinical correlations to some psychotic states. Acta Psychiatr Scand 57:153–164
Naber D, Pickar D, Post RM, Van Kammen DP, Waters RN, Ballenger JC, Goodwin FK, Bunney WE (1981) Endogenous opioid activity and β-endorphin immunoreactivity in CSF of psychiatric patients and normal volunteers. Am J Psychiatry 138:1457–1462
Panksepp J (1979) A neurochemical theory of autism. TINS 2:174–177
Sarne Y, Azov R, Weissman BA (1978) A stable enkephalin-like immunoreactive substance in human CSF. Brain Res 151: 399–403
Sarne Y, Gothilf Y, Weissman BA (1980) Humoral endorphin: Endogenous opiate in blood, cerebrospinal fluid and brain. In: Way EL (ed) Endogenous and exogenous opiate agonists and antagonists. Pergamon Press, New York, pp 317–320
Sarne Y, Weissman BA, Keren O, Urca G (1981) Humoral endorphin: a new endogenous factor with opiate-like activity. Life Sci 28:673–680
Sarne Y, Itzhak Y, Keren O (1982a) Differential effect of humoral endorphin on the binding of opiate agonists and antagonists. Eur J Pharmacol 81:227–235
Sarne Y, Weissman BA, Urca G (1982b) Differential effects of long-term electroconvulsive shock on brain levels of enkephalin and humoral endorphin. J Neurochem 39:1478–1480
Tamminga CA, Tighe PJ, Chase TN, De Fraites GE, Schaffer MH (1981) Desthyrosine-γ-endorphin administration in chronic schizophrenics. Arch Gen Psychiatry 38:167–169
Terenius L, Wahlstrom A, Lindstrom L, Widerlov E (1976) Increased CSF levels of endorphins in chronic psychosis. Neurosci Lett 3:157–162
Urca G, Harouni A, Sarne Y (1982) Electroconvulsive shock (ECS) and H-endorphin induced analgesia: unconventional interactions with naloxone. Eur J Pharmacol 81:237–243
Verhoeven WMA, Van Ree JM, De Wied D, Van Praag HM (1981) γ-type endorphins and schizophrenia. Arch Gen Psychiatry 38:1182
Watson SJ, Berger PA, Akil H, Mills MJ, Barchas J (1978) Effect of naloxone in schizophrenia: reductions in hallucinations in a subpopulation of subjects. Science 201:73–75
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Weizman, R., Weizman, A., Tyano, S. et al. Humoral-endorphin blood levels in autistic, schizophrenic and healthy subjects. Psychopharmacology 82, 368–370 (1984). https://doi.org/10.1007/BF00427687
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00427687